13G Filing: Woodford Investment Management and Northwest Biotherapeutics Inc (NWBO)

Page 2 of 8 – SEC Filing

SCHEDULE 13G

CUSIP NO. 66737P600

 1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

Woodford Investment Management Ltd

2

CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP                     (a)
þ

    (b)

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

United Kingdom

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY
EACH REPORTING

PERSON WITH

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

24,815,028 shares of Common Stock

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER


24,815,028 shares of Common Stock

 9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

24,815,028 shares of Common Stock

 10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES            ☐

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

8.4% (See Item 4)

 12

TYPE OF REPORTING PERSON

FI

2

Follow Northwest Biotherapeutics Inc (NASDAQ:NWBO)